Weekly Recap

NeurologyLive Weekly Recap

Each week on Saturday morning, the NeurologyLive^® team puts together a weekly recap that offers a quick look into some of the top headlines in neurology news that you may have missed.

Opicapone Treats Motor Fluctuations, Directional DBS Favored in PD, MRgFUS is Effective as Hand Tremor Treatment

Opicapone Treats Motor Fluctuations, Directional DBS Favored in PD, MRgFUS is Effective as Hand Tremor Treatment

NeurologyLive® Staff

September 19th 2020

Neurology News Network for the week ending September 19, 2020.

Pocket Card Treats Status Epilepticus, Pitolisant Shows No Cardiac Signals, SSRIs Associated With Increased Risk of Recurrent Stroke

Pocket Card Treats Status Epilepticus, Pitolisant Shows No Cardiac Signals, SSRIs Associated With Increased Risk of Recurrent Stroke

NeurologyLive® Staff

September 12th 2020

Neurology News Network for the week ending September 12, 2020.

Lacosamide Meets Primary End Point, Lemborexant Well-Tolerated in Elders, Cala Trio Reduces Hand Tremor

Lacosamide Meets Primary End Point, Lemborexant Well-Tolerated in Elders, Cala Trio Reduces Hand Tremor

NeurologyLive® Staff

September 5th 2020

Neurology News Network for the week ending September 5, 2020.

MS Physical Activity Recommendations, FDA Approves Celecoxib, Rituximab Effect on Myasthenia Gravis

MS Physical Activity Recommendations, FDA Approves Celecoxib, Rituximab Effect on Myasthenia Gravis

NeurologyLive® Staff

Neurology News Network for the week ending May 9, 2020.

Risdiplam Meets End Point, Fenfluramine Effective in Treating Dravet Syndrome, Rimegepant Sees Early Results in Migraine

Risdiplam Meets End Point, Fenfluramine Effective in Treating Dravet Syndrome, Rimegepant Sees Early Results in Migraine

NeurologyLive® Staff

Neurology News Network for the week ending May 2.

Daridorexant Improves Daytime Sleepiness, Vutrisiran Gains Fast Track Designation, Erenumab Effective in Migraine

Daridorexant Improves Daytime Sleepiness, Vutrisiran Gains Fast Track Designation, Erenumab Effective in Migraine

NeurologyLive® Staff

April 25th 2020

Neurology News Network for the week ending April 25, 2020.

Neurologic Symtpoms of COVID19, Rimegepant Available Via Telemedicine, Natalizumab

Neurologic Symtpoms of COVID19, Rimegepant Available Via Telemedicine, Natalizumab

NeurologyLive® Staff

April 18th 2020

Neurology News Network for the week ending April 18, 2020.

Risdiplam PDUFA Pushed Back, Masitinib Gains NDA, COVID19 Affects CNS

Risdiplam PDUFA Pushed Back, Masitinib Gains NDA, COVID19 Affects CNS

NeurologyLive® Staff

April 11th 2020

Neurology News Network for the week ending April 11, 2020.

CBD Under FDA Review, Rimegepant Meets Endpoint, Sleep-Disordered Breathing Associated With Alzheimer Disease

CBD Under FDA Review, Rimegepant Meets Endpoint, Sleep-Disordered Breathing Associated With Alzheimer Disease

NeurologyLive® Staff

Neurology News Network for the week ending April 4, 2020.

Teleheath Webinar on COVID-19 Now Available, Coronavirus' Effect on MS Patients, New Mind Moments Podcast

Teleheath Webinar on COVID-19 Now Available, Coronavirus' Effect on MS Patients, New Mind Moments Podcast

NeurologyLive® Staff

March 21st 2020

Neurology News Network for the week ending March 21, 2020.

Cenobamate Gets Schedule V Designation, ICER Publishes Migraine Treatment Review, FDA Approves RNS System Labeling Update

Cenobamate Gets Schedule V Designation, ICER Publishes Migraine Treatment Review, FDA Approves RNS System Labeling Update

NeurologyLive® Staff

March 14th 2020

Neurology News Network for the week ending March 14, 2020.

FDA Approves Rimegepant, Results on Ofatumumab Trial, Diazepam Becomes Commercially Available

FDA Approves Rimegepant, Results on Ofatumumab Trial, Diazepam Becomes Commercially Available

NeurologyLive® Staff

Neurology News Network for the week ending March 7, 2020.

Augusto Miravalle, MD: How Cladribine Sets Itself Apart in MS

Augusto Miravalle, MD: How Cladribine Sets Itself Apart in MS

Augusto Miravalle, MD

The associate professor in the department of neurology at the University of Colorado and neurologist at Advanced Neurology of Colorado discussed the advantages of cladribine and details of the ongoing CLICK-MS study.

Huntington Disease Trial Results; Mind Moments Podcast Now Live; PMM Trial Falls Short

Huntington Disease Trial Results; Mind Moments Podcast Now Live; PMM Trial Falls Short

NeurologyLive® Staff

January 4th 2020

Neurology News Network for the week ending January 4, 2020.

CBD Reduces Seizures in Tuberous Sclerosis Complex, Fenfluramine Reduces Seizure Frequency While Improving Executive Function, Intranasal Diazepam Effective to Treat Seizures Regardless of Usage Frequency

CBD Reduces Seizures in Tuberous Sclerosis Complex, Fenfluramine Reduces Seizure Frequency While Improving Executive Function, Intranasal Diazepam Effective to Treat Seizures Regardless of Usage Frequency

NeurologyLive® Staff

December 14th 2019

Neurology News Network for the week ending December 14, 2019.

Risdiplam Shows Positive Results in SMA, Study Trials for DMD Discontinued, Neflamapimod Granted Fast Track for Treatment of Dementia with Lewy Bodies

Risdiplam Shows Positive Results in SMA, Study Trials for DMD Discontinued, Neflamapimod Granted Fast Track for Treatment of Dementia with Lewy Bodies

NeurologyLive® Staff

November 16th 2019

Neurology News Network for the week ending November 16, 2019.

$Aducanumab Reversal Sends Drug to FDA, Cala Trio Reduces Hand Tremor, Ganaxolone Promising in Refractory Status Epilepticus$

Aducanumab Reversal Sends Drug to FDA, Cala Trio Reduces Hand Tremor, Ganaxolone Promising in Refractory Status Epilepticus

NeurologyLive® Staff

October 26th 2019

Neurology News Network for the week ending October 26, 2019.

Lasmiditan Approved for Acute Migraine, Istradefylline Now Available for Parkinson Off Episodes, Omaveloxolone Promising in Friedreich's Ataxia

Lasmiditan Approved for Acute Migraine, Istradefylline Now Available for Parkinson Off Episodes, Omaveloxolone Promising in Friedreich's Ataxia

NeurologyLive® Staff

October 19th 2019

Neurology News Network for the week ending October 19, 2019.

RimabotulinumtoxinB for Sialorrhea, Zogenix Resubmits Fenfluramine NDA, Long-Term Lemborexant Insomnia Data

RimabotulinumtoxinB for Sialorrhea, Zogenix Resubmits Fenfluramine NDA, Long-Term Lemborexant Insomnia Data

NeurologyLive® Staff

October 5th 2019

Neurology News Network for the week ending October 5, 2019.

EMA Removes Pregnancy Contraindications From MS Drugs, Oral Tavapadon Effective in Early-Stage Parkinson Disease, Pimavanserin Reduces Depression in PD

EMA Removes Pregnancy Contraindications From MS Drugs, Oral Tavapadon Effective in Early-Stage Parkinson Disease, Pimavanserin Reduces Depression in PD

NeurologyLive® Staff

September 28th 2019

Neurology News Network for the week ending September 28, 2019.

STOP 301 Trial of INP104 Initiated, Suvodirsen Gets Fast Track Designation, Siponimod EXPAND Data

STOP 301 Trial of INP104 Initiated, Suvodirsen Gets Fast Track Designation, Siponimod EXPAND Data

NeurologyLive® Staff

September 21st 2019

Neurology News Network for the week ending September 21, 2019.

Acadia Halts Phase 3 Pimavanserin Trial, Ofatumumab Superior In MS, Satralizumab Shines in NMOSD at ECTRIMS 2019

Acadia Halts Phase 3 Pimavanserin Trial, Ofatumumab Superior In MS, Satralizumab Shines in NMOSD at ECTRIMS 2019

NeurologyLive® Staff

September 14th 2019

Neurology News Network for the week ending September 14, 2019.

MS Immunization Guidelines, Prognostic Value of NfL in ALS, the Future of Focused Ultrasound

MS Immunization Guidelines, Prognostic Value of NfL in ALS, the Future of Focused Ultrasound

NeurologyLive® Staff

September 7th 2019

Neurology News Network for the week ending September 7, 2019.

Istradefylline OK'd for Parkinson, RimabotulinumtoxinB Approved for Chronic Sialorrhea, Dementia in Chronic Truamatic Encephalopathy

Istradefylline OK'd for Parkinson, RimabotulinumtoxinB Approved for Chronic Sialorrhea, Dementia in Chronic Truamatic Encephalopathy

NeurologyLive® Staff

August 31st 2019

Neurology News Network for the week ending August 31, 2019.

FDA Rejects Duchenne Muscular Dystrophy Drug Golodirsen, Pfizer Recalls Acute Migraine Treatment Relpax, Alzheimer Disease Update

FDA Rejects Duchenne Muscular Dystrophy Drug Golodirsen, Pfizer Recalls Acute Migraine Treatment Relpax, Alzheimer Disease Update

NeurologyLive® Staff

August 24th 2019

Neurology News Network for the week ending August 24, 2019.

Impact of Caregiver Depression on Patients With Dementia, CAG Repeat Length Predicts Huntington Disease Decline, Novel Oral CBD Formulation Effective in Epilepsy

Impact of Caregiver Depression on Patients With Dementia, CAG Repeat Length Predicts Huntington Disease Decline, Novel Oral CBD Formulation Effective in Epilepsy

NeurologyLive® Staff

August 17th 2019

Neurology News Network for the week ending August 17, 2019.

Zolgensma Gene Therapy Data Manipulation, GRF6019 Phase 2 Results in Mild to Moderate Alzheimer, Mind Moments Podcast

Zolgensma Gene Therapy Data Manipulation, GRF6019 Phase 2 Results in Mild to Moderate Alzheimer, Mind Moments Podcast

NeurologyLive® Staff

August 10th 2019

Neurology News Network for the week ending August 10, 2019.

Tic Suppression Ability Predicts Future Symptom Outcomes, Wearable-Detected Gait Changes Predict Parkinson Disease, Early MRI Scans Predict Relapse-Onset Multiple Sclerosis

Tic Suppression Ability Predicts Future Symptom Outcomes, Wearable-Detected Gait Changes Predict Parkinson Disease, Early MRI Scans Predict Relapse-Onset Multiple Sclerosis

NeurologyLive® Staff

August 3rd 2019

Neurology News Network for the week ending August 3, 2019.

Highlights From the 2019 American Headache Society Annual Scientific Meeting

Highlights From the 2019 American Headache Society Annual Scientific Meeting

NeurologyLive® Staff

This week’s edition features highlights from NeurologyLive’s coverage of the American Headache Society’s annual scientific meeting.

Parkinson Disease Gene Therapy PR001 Granted Fast Track Designation, Telerehabilitation Similar to In-Clinic Rehab for Stroke, New Therapeutic Technologies In Epilepsy

Parkinson Disease Gene Therapy PR001 Granted Fast Track Designation, Telerehabilitation Similar to In-Clinic Rehab for Stroke, New Therapeutic Technologies In Epilepsy

NeurologyLive® Staff

Neurology News Network for the week ending July 13, 2019.

...

4 5 6 7 8 9 10 >

Do Not Sell My Information

Terms and Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2024 MJH Life Sciences

All rights reserved.